Foseco India (FOSECOIND)

FairStock Score: 17/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I wear two hats: Graham’s accountant and Buffett’s business buyer. Foseco India, at ₹5655 and a ₹4,283 Cr market cap, is a specialty chemicals business with 63.54% promoter holding, a 19.20% five-year revenue CAGR, and 16.22% sales growth. That suggests a decent niche franchise and promoter alignment. The latest quarter shows ₹187 Cr sales and ₹15 Cr net profit, roughly an 8% net margin, while ROE is 13.25% and ROCE 17.36%. Those are respectable but not exceptional. A Piotroski F-Score of 7/9 is a positive sign of financial strength. However, Debt/Equity is not available, so I cannot fully underwrite leverage. The stated free cash flow of ₹74.29 lakh Cr appears anomalous against a ₹4,283 Cr market cap, so I would set it aside until verified. The real problem is valuation. At P/E 46.51, P/B 4.11, and book value ₹1,374.84, I am paying a rich price for moderate profitability. Profit growth of 6.17% badly trails sales growth, and PEG is 2.09, suggesting the market may be overpaying for growth. Dividend yield is only 0.44%, so there is little income support. The 52-week range of ₹4,300–₹7,384.65 shows volatility, and the FairStock Score of 17/100 flags risk. My conclusion: the business has revenue momentum and promoter skin in the game, but the economics are only moderate and the valuation leaves no margin of safety. I would classify it as a Stalwart, but at this price it is not a bargain. I would wait for faster profit conversion or a lower multiple.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer